Bio Green Med Solution (BGMS) Raw Materials (2025 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Raw Materials of $238000.0 for Q1 2026, down 1.65% quarter-over-quarter from $242000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Raw Materials (2025 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Raw Materials for 2 consecutive years, with $238000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Raw Materials changed N/A year-over-year to $238000.0; the TTM figure through Mar 2026 stood at $238000.0 (changed N/A YoY), while the FY2025 annual figure was $242000.0, changed N/A from the prior year.
- Raw Materials retreated to $238000.0 in Q1 2026 per BGMS's latest filing, from $242000.0 in the prior quarter.
- Across five years, Raw Materials topped out at $242000.0 in Q4 2025 and bottomed at $190000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.38 Bn | 133.52 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.87 Bn | 1.37 Bn |
| 4 | Moderna | 57.47 Bn | 52.34 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.67 Bn | 44.67 Bn | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.37 Bn | 32.06 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.15 Bn | 27.31 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 238,000.00 |
| Mar 31, 2026 | 238,000.00 |
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 190,000.00 |